LINC01134: A Drug Target / Disease Biomarker (G100133612)

Target Name: LINC01134

NCBI ID: G100133612

LINC01134

Other Name(s): TLNC1 | Long intergenic non-protein coding RNA 1134 | long intergenic non-protein coding RNA 1134

LINC01134: A Drug Target / Disease Biomarker

LINC01134 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, and is involved in the development and maintenance of normal cell structure and function.

Research has identified LINC01134 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. This is because LINC01134 is involved in many important cellular processes that are disrupted in these conditions, and may be a useful target for new treatments.

One of the key reasons for the potential of LINC01134 as a drug target is its involvement in the cell cycle. The cell cycle is the process by which cells grow, divide, and replicate their genetic material. LINC01134 is a key regulator of the cell cycle, and is involved in the development and maintenance of the normal cell structure and function that is required for the cell to divide and replicate properly.

Disruptions in the cell cycle, such as those that occur in cancer, can lead to the development of uncontrolled cell growth and the formation of tumors. LINC01134 may be a useful drug target for these conditions, as it can be targeted directly to disrupt the cell cycle and inhibit the formation of these dangerous structures.

Another potential use of LINC01134 as a drug target is its involvement in neurodegenerative diseases. These conditions, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and other abnormal structures. LINC01134 may be a useful drug target for these conditions, as it is involved in the development and maintenance of the normal brain structure and function that is required for the brain to function properly.

In addition to its potential use as a drug target, LINC01134 has also been identified as a potential biomarker for a variety of diseases. This is because it is expressed in various tissues throughout the body, and its levels can be used as a diagnostic or predictive marker for a range of conditions. For example, LINC01134 has been identified as a potential biomarker for cancer, and may be used as a diagnostic marker for this condition.

Overall, LINC01134 is a protein that has the potential to be a drug target for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Its involvement in the cell cycle and its potential as a biomarker make it an attractive target for new treatments. Further research is needed to fully understand the role of LINC01134 in these conditions, and to determine its safety and effectiveness as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 1134

The "LINC01134 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01134 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets